Abstract 6696: A senescent whole-cell vaccine platform derived from conditionally reprogrammed primary tumor cells primes potent T-cell immunity and overcomes ICI resistance in murine breast cancer models
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Sara Rasouli, Chongwen Cao, Weiyi Gong, Haichang Li, Bei Liu, Anna Vilgelm, Jenny Li, Xuefeng Liu
Institution: The Ohio State University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148651489
Cites:
Cited by:
Related to: